Epstein-Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression - PubMed
4 hours ago
- #Autoimmunity
- #B Cells
- #Epstein-Barr Virus
- Epstein-Barr virus (EBV) is a significant environmental risk factor in autoimmune diseases like systemic lupus erythematosus (SLE) and multiple sclerosis (MS).
- EBV infects memory B cells, alternating between lytic (active) and latent (dormant) infection phases.
- The study proposes two mechanisms: lytic switching contributes to SLE, while latency III is more crucial in MS development.
- EBV-transformed lymphoblastoid cell lines from SLE, MS, and healthy controls were analyzed for EBV gene expression.
- Findings support the proposed model, highlighting distinct EBV lifecycle phases in SLE and MS.
- This research offers insights into EBV's role in autoimmunity and potential pathways for new treatments.